Literature DB >> 31691397

Differences in nicotine intake and effects from electronic and combustible cigarettes among dual users.

Gideon St Helen1,2,3, Natalie Nardone1,3, Newton Addo1, Delia Dempsey1, Christopher Havel1, Peyton Jacob1,2,3, Neal L Benowitz1,2,3,4.   

Abstract

AIM: To describe systemic nicotine exposure and subjective effects of electronic cigarettes (e-cigarettes) in people who use both e-cigarettes and cigarettes (dual users), including within-subject comparisons of e-cigarette and cigarette use.
DESIGN: Two-arm, counterbalanced cross-over study. Participants used their usual brand of e-cigarette or cigarette during a standardized session in a 2-week study.
SETTING: Hospital research ward, San Francisco, CA, USA. PARTICIPANTS: Thirty-six healthy (eight women, 28 men) participants. MEASUREMENTS: Plasma nicotine was analyzed by gas chromatography-tandem mass spectrometry; nicotine withdrawal, urge to smoke and vape, affective states, craving, satisfaction and psychological reward were measured by standardized questionnaires.
FINDINGS: Compared with cigarettes, average maximum plasma nicotine concentration (Cmax ) was lower with e-cigarettes [6.1 ± 5.5 ng/ml, mean ± standard deviation (SD) versus 20.2 ± 11.1 ng/ml, P < 0.001] and time of maximal concentration (Tmax ) was longer (6.5 ± 5.4 versus 2.7 ± 2.4 minutes, P < 0.001). Use of both products resulted in a reduction in the severity of withdrawal symptoms, negative affect and urge to use either product. E-cigarettes were less rewarding and satisfying and reduced craving to a lesser degree than cigarettes. We were not able to detect any differences in withdrawal symptoms, affective states and urge to smoke cigarettes between e-cigarette and cigarette use.
CONCLUSION: Systemic nicotine exposure was, on average, lower with single use of e-cigarettes compared with cigarettes, and e-cigarettes were judged to be less satisfying and rewarding and reduced craving less than cigarettes.
© 2020 Society for the Study of Addiction.

Entities:  

Keywords:  Dual users; JUUL PK profile; e-cigarette dependence; e-cigarettes; nicotine pharmacokinetics; subjective effects

Mesh:

Substances:

Year:  2020        PMID: 31691397      PMCID: PMC7339816          DOI: 10.1111/add.14884

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  34 in total

1.  Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings.

Authors:  L S Cox; S T Tiffany; A G Christen
Journal:  Nicotine Tob Res       Date:  2001-02       Impact factor: 4.244

2.  Individual differences in nicotine intake per cigarette.

Authors:  Freda Patterson; Neal Benowitz; Peter Shields; Vyga Kaufmann; Christopher Jepson; Paul Wileyto; Susan Kucharski; Caryn Lerman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-05       Impact factor: 4.254

3.  The early time course of smoking withdrawal effects.

Authors:  Peter S Hendricks; Joseph W Ditre; David J Drobes; Thomas H Brandon
Journal:  Psychopharmacology (Berl)       Date:  2006-06-03       Impact factor: 4.530

4.  Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes.

Authors:  Gideon St Helen; Delia A Dempsey; Christopher M Havel; Peyton Jacob; Neal L Benowitz
Journal:  Drug Alcohol Depend       Date:  2017-06-30       Impact factor: 4.492

5.  E-cigarettes generate high levels of aldehydes only in 'dry puff' conditions.

Authors:  Konstantinos E Farsalinos; Vassilis Voudris; Konstantinos Poulas
Journal:  Addiction       Date:  2015-05-20       Impact factor: 6.526

6.  Self-titration by experienced e-cigarette users: blood nicotine delivery and subjective effects.

Authors:  Lynne E Dawkins; Catherine F Kimber; Mira Doig; Colin Feyerabend; Olivia Corcoran
Journal:  Psychopharmacology (Berl)       Date:  2016-05-27       Impact factor: 4.530

7.  Nicotine levels, withdrawal symptoms, and smoking reduction success in real world use: A comparison of cigarette smokers and dual users of both cigarettes and E-cigarettes.

Authors:  Douglas E Jorenby; Stevens S Smith; Michael C Fiore; Timothy B Baker
Journal:  Drug Alcohol Depend       Date:  2016-11-09       Impact factor: 4.492

8.  Nicotine Delivery and Vaping Behavior During ad Libitum E-cigarette Access.

Authors:  Gideon St Helen; Kathryn C Ross; Delia A Dempsey; Christopher M Havel; Peyton Jacob; Neal L Benowitz
Journal:  Tob Regul Sci       Date:  2016-10

9.  Nicotine Replacement, Topography, and Smoking Phenotypes of E-cigarettes.

Authors:  Andrew A Strasser; Valentina Souprountchouk; Amanda Kaufmann; Sonja Blazekovic; Frank Leone; Neal L Benowitz; Robert A Schnoll
Journal:  Tob Regul Sci       Date:  2016-10

10.  Signs and symptoms of tobacco withdrawal.

Authors:  J R Hughes; D Hatsukami
Journal:  Arch Gen Psychiatry       Date:  1986-03
View more
  16 in total

Review 1.  Recent findings in the pharmacology of inhaled nicotine: Preclinical and clinical in vivo studies.

Authors:  Asti Jackson; Ben Grobman; Suchitra Krishnan-Sarin
Journal:  Neuropharmacology       Date:  2020-06-24       Impact factor: 5.250

2.  Clinical Pharmacology of Electronic Nicotine Delivery Systems (ENDS): Implications for Benefits and Risks in the Promotion of the Combusted Tobacco Endgame.

Authors:  Neal L Benowitz; Gideon St Helen; Evangelia Liakoni
Journal:  J Clin Pharmacol       Date:  2021-08       Impact factor: 2.860

Review 3.  Electronic cigarettes for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Hayden McRobbie; Ailsa R Butler; Nicola Lindson; Chris Bullen; Rachna Begh; Annika Theodoulou; Caitlin Notley; Nancy A Rigotti; Tari Turner; Thomas R Fanshawe; Peter Hajek
Journal:  Cochrane Database Syst Rev       Date:  2021-09-14

4.  Effect of Electronic Nicotine Delivery Systems on Cigarette Abstinence in Smokers With No Plans to Quit: Exploratory Analysis of a Randomized Placebo-Controlled Trial.

Authors:  Jonathan Foulds; Caroline O Cobb; Miao-Shan Yen; Susan Veldheer; Phoebe Brosnan; Jessica Yingst; Shari Hrabovsky; Alexa A Lopez; Sophia I Allen; Christopher Bullen; Xi Wang; Chris Sciamanna; Erin Hammett; Breianna L Hummer; Courtney Lester; John P Richie; Nadia Chowdhury; Jacob T Graham; Le Kang; Shumei Sun; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2022-06-15       Impact factor: 5.825

5.  The interaction of nicotine concentration and device power on electronic nicotine delivery system (ENDS) abuse liability among exclusive ENDS users and dual users of ENDS and combustible cigarettes.

Authors:  Cosima Hoetger; Rose S Bono; Augustus M White; Andrew J Barnes; Caroline O Cobb
Journal:  Exp Clin Psychopharmacol       Date:  2021-10-14       Impact factor: 3.492

6.  Twenty-four-hour subjective and pharmacological effects of ad-libitum electronic and combustible cigarette use among dual users.

Authors:  Arit M Harvanko; Gideon St Helen; Natalie Nardone; Newton Addo; Neal L Benowitz
Journal:  Addiction       Date:  2020-02-06       Impact factor: 6.526

7.  Electronic cigarettes for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Hayden McRobbie; Nicola Lindson; Chris Bullen; Rachna Begh; Annika Theodoulou; Caitlin Notley; Nancy A Rigotti; Tari Turner; Ailsa R Butler; Thomas R Fanshawe; Peter Hajek
Journal:  Cochrane Database Syst Rev       Date:  2021-04-29

Review 8.  Nicotine delivery and cigarette equivalents from vaping a JUULpod.

Authors:  Judith J Prochaska; Erin A Vogel; Neal Benowitz
Journal:  Tob Control       Date:  2021-03-24       Impact factor: 6.953

9.  A Descriptive Analysis of Transitions from Smoking to Electronic Nicotine Delivery System (ENDS) Use: A Daily Diary Investigation.

Authors:  Tamlin S Conner; Jiaxu Zeng; Mei-Ling Blank; Vicky He; Janet Hoek
Journal:  Int J Environ Res Public Health       Date:  2021-06-10       Impact factor: 3.390

10.  Electronic cigarettes for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Hayden McRobbie; Nicola Lindson; Chris Bullen; Rachna Begh; Annika Theodoulou; Caitlin Notley; Nancy A Rigotti; Tari Turner; Ailsa R Butler; Peter Hajek
Journal:  Cochrane Database Syst Rev       Date:  2020-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.